MedPath
TGA Approval

IMFINZI durvalumab (rch) 120 mg concentrated injection vial (283215)

283215

IMFINZI durvalumab (rch) 120 mg concentrated injection vial

AstraZeneca Pty Ltd

October 1, 2018

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/607018c2ce26a318cc9bc8b1870f3154.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/c66c7847365c5cd6a81fe8dd142963b8.pdf

Active Ingredients

durvalumab

© Copyright 2025. All Rights Reserved by MedPath